1492 Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.65M Sell
51,501
-4,271
-8% -$362K 1.37% 24
2026
Q1
$4.66M Sell
55,772
-155
-0.3% -$12.7K 1.77% 16
2025
Q4
$5.12M Buy
55,927
+955
+2% +$91.4K 1.96% 15
2025
Q3
$5.21M Buy
54,972
+2,894
+6% +$272K 2.11% 13
2025
Q2
$5.46M Sell
52,078
-806
-2% -$76.4K 2.51% 9
2025
Q1
$4.67M Buy
52,884
+7,490
+16% +$768K 2.51% 12
2024
Q4
$4.36M Sell
45,394
-445
-1% -$41.5K 2.07% 18
2024
Q3
$3.75M Buy
+45,839
New +$3.54M 1.87% 21

Other funds holding HQY

1492 Capital Management's HQY Position: Q2 2026 in Review

1492 Capital Management reduced its HealthEquity (HQY) stake by 7.7% in Q2 2026, selling an estimated $362K and leaving 51,501 shares worth $4.65M. The position accounts for 1.37% of the portfolio, ranked #24.

1492 Capital Management first reported a position in HQY in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.46M in Q2 2025. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • 1492 Capital Management held 51,501 shares of HealthEquity worth $4.65M as of Q2 2026.
  • 1492 Capital Management sold 4,271 HealthEquity shares in Q2 2026, an estimated $362K.
  • HealthEquity made up 1.37% of 1492 Capital Management's portfolio in Q2 2026, its #24 holding.
  • 1492 Capital Management first reported a position in HealthEquity in Q3 2024 and has held it in 8 quarters since.
  • 1492 Capital Management's HealthEquity position peaked at $5.46M in Q2 2025.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on 1492 Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.